Familial candidiasis

Lanternier F et al. (2013) Deep dermatophytosis and inherited CARD9 deficiency.

Hartono SP et al. (2018) Novel STAT1 Gain-of-Function Mutation Presenting as Combined Immunodeficiency.

Mangino M et al. (2003) A gene for familial isolated chronic nail candidiasis maps to chromosome 11p12-q12.1.

Germain M et al. (1994) Case report: familial chronic mucocutaneous candidiasis complicated by deep candida infection.

Ee HL et al. (2005) Autosomal dominant familial chronic mucocutaneous candidiasis associated with acne rosacea.

Zuccarello D et al. (2002) Familial chronic nail candidiasis with ICAM-1 deficiency: a new form of chronic mucocutaneous candidiasis.

Atkinson TP et al. (2001) An immune defect causing dominant chronic mucocutaneous candidiasis and thyroid disease maps to chromosome 2p in a single family.

Loeys BL et al. (1999) Fungal intracranial aneurysm in a child with familial chronic mucocutaneous candidiasis.

Zimmermann-Belsing T et al. (1994) Riedel's thyroiditis: an autoimmune or primary fibrotic disease?

Jorizzo JL et al. (1980) Cimetidine as an immunomodulator: chronic mucocutaneous candidiasis as a model.

Montes LF et al. (1971) Prolonged oral treatment of chronic mucocutaneous candidiasis with Amphotericin B.

Wells RS et al. (1972) Familial chronic muco-cutaneous candidiasis.

Canales L et al. (1969) Immunological observations in chronic mucocutaneous candidiasis.

Sams WM et al. (1979) Chronic mucocutaneous candidiasis. Immunologic studies of three generations of a single family.

Ling Y et al. (2015) Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis.

Ho AW et al. (2010) IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail.

van de Veerdonk FL et al. (2011) STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis.

Drewniak A et al. (2013) Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency.

Boudghène-Stambouli O et al. (1998) [Dermatophytic disease: exuberant hyperkeratosis with cutaneous horns].

Boisson B et al. (2013) An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis.

Ferwerda B et al. (2009) Human dectin-1 deficiency and mucocutaneous fungal infections.

Glocker EO et al. (2009) A homozygous CARD9 mutation in a family with susceptibility to fungal infections.

Lévy R et al. (2016) Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency.

Puel A et al. (2011) Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity.

Kudva A et al. (2011) Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice.

Tan W et al. (2006) IL-17 receptor knockout mice have enhanced myelotoxicity and impaired hemopoietic recovery following gamma irradiation.

Yamazaki Y et al. (2014) Two novel gain-of-function mutations of STAT1 responsible for chronic mucocutaneous candidiasis disease: impaired production of IL-17A and IL-22, and the presence of anti-IL-17F autoantibody.

Soltész B et al. (2013) New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe.

Sampaio EP et al. (2013) Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis.

Uzel G et al. (2013) Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome.

Smeekens SP et al. (2011) STAT1 hyperphosphorylation and defective IL12R/IL23R signaling underlie defective immunity in autosomal dominant chronic mucocutaneous candidiasis.

Liu L et al. (2011) Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.